The OPENS Trial: Offering Women PrEP (Aim 2)

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Nov 14, 2022

Keywords

ClinConnect Summary

The OPENS Trial is a study aimed at improving access to HIV prevention methods, specifically for women, particularly women of color, in Duval County, Florida. This area has one of the highest rates of HIV infections among women in the U.S. The trial is investigating new ways to help women learn about HIV risks and prevention options through a decision support tool that can be used on a tablet. The study also includes training for clinic staff to ensure they provide supportive and understanding care when discussing HIV prevention. Participants will take part in two phases: first, they will receive care at a trained clinic without using the tablet tool, and then they will use the tool before their visit to help them make informed decisions.

To participate, women aged 18 to 45 who speak English and are not living with HIV can join the study. It's important that they are interested in learning about HIV prevention options. Participants will share their experiences with HIV prevention counseling and their thoughts on using prevention methods like PrEP (a medication that helps prevent HIV). The study will also follow up with participants three months later to see if they started using any HIV prevention methods. This trial aims to provide valuable insights into how to better support women in making informed choices about their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Self-identify as a woman (regardless of pregnancy status)
• • Age 18 years - 45 years
• • Not known to be living with HIV (based on self-report)
• • English speaking
• • Interested in participating in the study
• Exclusion Criteria:
• • Unable to consent
• • Currently using PrEP
• • Those who were assigned male at birth and self-identify as a man
• • Unwilling to be contacted in 3 months